Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2004; 9: 10
The aim of this study was to assess the effects of Linum usitatissimum (flaxseed) supplementation on lipid profile in healthy menopausal women.
In a randomised, double-blind clinical trial, 199 menopausal women were randomly assigned to consume 40 g daily of L. usitatissimum (n = 101), a lignan-rich food, or wheatgerm placebo (n = 98) for 12 months. At baseline and at each visit (months 3, 6, 9 and 12) serum levels of lipids and lipoprotein fractions and anthropometric measures were evaluated.
Among the 199 women followed for 1 year, a total of 179 women were available for the ITT. L. usitatissimum supplementation reduced serum total (P = 0.012) and HDL-C (P = 0.031) concentrations compared with the placebo arm, whereas reduction in LDL-C levels was significantly borderline (P = 0.086). There was no difference in fasting serum triglyceride and glucose levels between the two arms. In the L. usitatissimum arm, significant reductions in weight (P = 0.016) and body mass index (P = 0.036) were observed compared with the placebo. There were no changes in statistical significance after adjustments for age, weight and body mass index.
Our findings suggest that 1 year of incorporation of L. usitatissimum in the diet produces a favourable but not clinically significant effect on blood cholesterol in menopausal women.
This study was supported by the Flax Council of Canada, the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada.